Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials

Ocular toxicities arising from anti-cancer drugs occur sporadically and are sometimes underestimated because they are not life-threatening. Reports focusing on ocular toxicities from cancer therapy are limited. We investigated the detailed progress of ocular toxicities of anti-cancer drugs including...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamizawa, Shigemasa, Katsuya, Yuki, Chen, Yi-Ning, Mizuno, Takaaki, Koyama, Takafumi, Sudo, Kazuki, Yoshida, Tatsuya, Kondo, Shunsuke, Iwasa, Satoru, Yonemori, Kan, Shimizu, Toshio, Yamamoto, Noboru, Suzuki, Shigenobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030433/
https://www.ncbi.nlm.nih.gov/pubmed/36471215
http://dx.doi.org/10.1007/s10637-022-01321-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030433/
https://www.ncbi.nlm.nih.gov/pubmed/36471215
http://dx.doi.org/10.1007/s10637-022-01321-8

Ejemplares similares